Bruush Oral Care Inc. BRSHF
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $8.7M
- P/E
- 0.0×
Follow BRSHF
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '22 | Jan '23 | Mar '23 | Apr '23 | |
|---|---|---|---|---|---|
|
+5 more TTM periods Free account |
— | 0.00% | 199.66% | 131.00% | |
| 0.00% | 0.00% | (630.83%) | (413.95%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 126.77% | 83.26% | |
Average Days of Receivables |
0.00 | 0.00 | 32.39 | 31.95 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | (19.04) | |
Free Cash Flow |
(0.12) | (0.12) | (1.39) | (9.50) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Piotroski F-Score |
— | — | 1.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
9.55% | 9.58% | 52.39% | 358.87% | |
Accounts Receivable Turnover |
— | 0.00 | 10.49 | 10.63 | |
Accounts Payable Turnover |
— | 0.00 | 0.69 | 0.68 | |
Inventory Turnover |
— | 0.00 | 6.58 | 6.48 | |
Average Days of Payables |
0.00 | 0.00 | 666.97 | 676.76 | |
Days of Inventory on Hand |
0.00 | 0.00 | 41.31 | 41.92 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.09% | 0.17% | |
Selling, General and Administrative Expense of Revenue |
— | — | 531.41% | 533.91% | |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | |
Interest Coverage |
— | — | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.21 | 2.20 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.86 | |
Capex/Depreciation |
(0.36) | (0.36) | (0.17) | (0.67) | |
Revenue per Share |
— | — | 0.00 | 3.50 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | (19.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
— | — | (381.86%) | (247.19%) |
Columns are period end dates